CytoMed Therapeutics Limited (GDTC) is a pioneering pre-clinical biopharmaceutical firm located in Singapore, focusing on the development of innovative cell-based immunotherapies to treat various forms of cancer. The company harnesses advanced technology and research to create proprietary therapeutic candidates that aim to fulfill significant unmet medical needs in oncology. With a robust pipeline and a commitment to leveraging cutting-edge science, CytoMed is strategically positioned in the dynamic landscape of cancer immunotherapy, making it an attractive opportunity for institutional investors looking to engage in the biopharmaceutical sector.
Click "Analyze" to generate stock analysis
GDTC Price Trend and Signals
GDTC Financials
2025-10-29Somewhat Bearishmacd_signal
Dead cross above zero detected.
2025-10-22Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-22Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-22Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-22Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.
2025-10-20Somewhat Bullishprice_signal
Half-yearly high detected.
2025-10-20Bullishprice_signal
Large price change detected: 17.47%.
2025-10-17Somewhat Bullishprice_signal
Quarterly high detected.
2025-10-16Somewhat Bullishprice_signal
Monthly high detected.
2025-10-15Somewhat Bullishprice_signal
Monthly high detected.
2025-10-14Somewhat Bullishmacd_signal
Golden cross above zero detected.
2025-10-14Neutralvolume_signal
Abnormal volume detected compared to 5-day moving average.
2025-10-14Neutralvolume_signal
Abnormal volume detected compared to 10-day moving average.
2025-10-14Neutralvolume_signal
Abnormal volume detected compared to 20-day moving average.
2025-10-14Neutralvolume_signal
Abnormal volume detected compared to 3 mon moving average.